摘要:
Embodiments of the invention relate generally to ex vivo methods of quantifying expression of leukocyte-function associated mRNAs and using the quantification to characterize an individual's potential responsiveness to cancer immunotherapy. Certain embodiments relate to methods to monitor the efficacy of ongoing cancer immunotherapy by evaluating expression of leukocyte-function associated mRNAs genes before and administration of an anti-cancer immunotherapy regimen.
摘要:
Embodiments of the invention relate generally to ex vivo methods of quantifying expression of interferon responsive genes and characterizing an individual's potential responsiveness to interferon administration. Certain embodiments relate to methods to monitor the efficacy of ongoing interferon therapy by evaluating expression of interferon responsive genes before and after interferon administration.
摘要:
To improve positioning accuracy in a direction of relative movement of dots which are formed by a fluid ejection device in which a plurality of nozzle groups contained in the direction of the relative movement of the head section contain a plurality of nozzles in the direction of the relative movement, an ejection timing is set for adjusting in a direction of the relative movement the positions of dots formed by each of nozzle groups. A distribution of adjustment pixels is set for adjusting in the direction of the relative movement the positions of dots formed by each of nozzles. A fluid is ejected in accordance with raster data generated on the basis of a distribution of the adjustment pixels set by an adjustment pixel setting unit, on the basis of ejection timing set by a nozzle group timing setting unit.
摘要:
The transport control section controls, at the time of cutting of the long sheet by the cutting unit, the motor for pinching such that a downstream portion in the transport direction, which is cut from the sheet, remains pinched by the first roller and the second roller at the point of time of completion of cutting, and controls, after the completion of cutting, the motor for discharge such that the downstream portion is discharged downstream in the transport direction by rotation of the respective rollers which pinch the downstream portion.
摘要:
Provided herein are primer/probe sets useful for detecting HIV (HIV-1) in a test sample. The primer/probe sets can be employed according to nucleic acid amplification procedures including PCR, real-time quantitative PCR, or RT-PCR. The primer/probe sets can also be provided in the form of a kit with other reagents for performing a nucleic acid amplification reaction.
摘要:
Providing a PM emission amount estimation device for the diesel engine wherein the accuracy of the correction in correcting the basic level of the PM emission amount by use of the PM emission amount estimation map can be enhanced; and, the PM emission amount particularly during the transient state of the engine operation condition can be accurately computed so as to estimate, with high precision, the PM emission amount and the PM emission accumulated-amount (integrated amount) during the whole engine operation conditions including the transient state as well as the steady state. A PM emission amount estimation device for estimating the amount of the PM for estimating the amount of the PM that is emitted from a diesel engine and collected by a DPF provided in the exhaust gas passage of the engine, the device including, but not limited to: a PM emission amount estimation base-map 3 with which the base PM emission amount is computed in response to the operation condition of the engine; a PM emission amount estimation correction-map 5 that determines a correction factor for correcting the base PM emission amount computed by the PM emission amount estimation base-map 3, the correction factor being determined in response to the transient engine operation condition; a transient state judgment device 7 that judges that the engine is operated in a transient operation condition based on the change of the air excess ratio regarding the engine; a PM emission amount computation device 9 that corrects the computed base PM emission amount by multiplying the computed base PM emission amount by the correction factor computed with the PM emission amount estimation correction-map 5 only in a case where it is judged, by the transient state judgment device 7, that the engine is in a transient operation condition whereas the base PM emission amount is directly outputted in a case where it is judged that the engine is in a steady operation condition.
摘要:
A fluorine-containing compound exhibiting excellent surface tension-reducing ability despite the absence of perfluoroalkyl group having a chain length of 8 or more which had been the cause of the PFOS and PFOA problems and use of a fluorine material with low environmental load is provided. Also provided are a fluorine-containing surfactant and a composition thereof, an aqueous resin emulsion and a floor polish composition containing such surfactant. The fluorine-containing compound is represented by the following formula (1): Rf1—CpH2p—CH(OH)—CqH2q—NR—CrH2r—(O)n—SO3M (1) wherein Rf1 is a C1-6 perfluoroalkyl group, p, q, and r are independently an integer of 1 to 6, M is a cationic atom or atomic group, n is 0 or 1, R is hydrogen atom, a C1-12 alkyl group, or a group represented by the following formula (2): Rf2—CsH2s—CH(OH)—CtH2t— (2) wherein Rf2 is a C1-6 perfluoroalkyl group, and s and t are independently an integer of 1 to 6.
摘要:
A method is disclosed for determining whether a human having Crohn's disease is likely to respond to a therapy targeting a TNFSF member or a cytokine by measuring the level of certain mRNAs in response to a stimulus. A method of evaluating the effectiveness of a Crohn's disease therapy in a human is also disclosed. Furthermore, a method of screening compounds for use in the treatment of Crohn's disease is disclosed. A method of monitoring the disease state over time in Crohn's disease patients is also disclosed.
摘要:
A method is disclosed for individually tailoring the administration of dietary components such as supplements. In the method, whole blood of a mammal is exposed to a dietary component. The level of a marker mRNA linked to a disease state is measured in leukocytes after exposure to the dietary component, and in some cases after further stimulation of the exposed blood cells. By comparing the mRNA level after exposure with the value found in unexposed blood cells, it is possible to determine what the effect of the dietary component will be in the mammal. By screening blood of the mammal against a number of possible dietary components, it is possible to develop an optimized set of dietary components tailored to the specific mammal to treat or prevent a disease state.
摘要:
Disclosed are a method, device kit, and automated system for simple, reproducible, and high-throughput quantification of mRNA from whole blood. More particularly, the method, device, kit and automated system involve combinations of leukocyte filters attached to oligo(dT)-immobilized multi-well plates.